Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats

Endocrine Regulations

Volumn 42, Issue 1, 2008, Pages 69-75

  Shehata, Mona ^a   El Nabi Kamel, Maher Abd ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Antioxidants; Cardiovascular diseases; Glucose; HRT; Insulin; Lipids; Ovariectomy; Rats

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN B; ASCORBIC ACID; ESTROGEN; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROGESTERONE; TRIACYLGLYCEROL; ANTIOXIDANT; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECT; ESTROGEN THERAPY; METABOLISM; METHODOLOGY; WISTAR RAT;

ADJUVANTS, PHARMACEUTIC; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; INSULIN; INSULIN RESISTANCE; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, WISTAR; VITAMIN E;

EID: 52649132823     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ALBERS JJ, WARMICK GR, CHENY MC: Determination of HDL-C. Lipids. 13, 926-32, 1978
2. BARBIKER F, LEON J et al: Estrogenic hormone action in the heart: regulatory network and function Cardiovasc Res 53, 709-709, 2002
3. BERTONI AG, WONG ND, SHEA S, MA S, LIU K, SRIKANTHAN P, JACOBS DR JR, WU C, SAAD MF, SZKLO M: Insulin Resistance, Metabolic Syndrome and Subclinical Atherosclerosis: The Multi-Ethnic study of Atherosclerosis (MESA). Diabetes Care 30, 2951-2956, 2007
4. BONNEFONT-ROUSSELOT D: Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 5, 561-568, 2002
5. BUCCOLO G, DAVID H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19, 476-482, 1973
6. CLEGG DJ, BROWN LM, WOODS SC, BENOIT SC: Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 55, 978-987, 2006
7. DRAPER HH, HADLEY M: Malodialdehyde determination as index of lipid peroxidation. Methods Enzymology. 105, 114-118, 1984
8. EL-SWEFY SE, ALI SI, ASKER ME, MOHAMED HE: Hyperhomocysteinemia and cardiovascular risk in female ovariectomized rats role of folic acid and hormone replacement therapy. Pharm Pharmacol 54, 391-397, 2002
9. FRANTZEN F, FAAREN AL, ALFHEIM I, NORDHEI AK: An enzyme conversion immunoassay for determination of total hmocysteine in plasma or serum. Clin Chem 44, 311-316, 1998
10. FRIEDWALD WT, LEVY RI, FREDRICKSON DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultra centrifuge Clin Chem 18, 499-502, 1972
11. GASPARD U, VAN DEN BRULE, PINTIAUX A, FOIDART JM: Clinical study of the month. Benefit/risk balance of postmenopausal estrogen progestin treatment in peril in the Women's Health Initiative Study: practical attitude of the clinician. Rev Med Liege 57, 556-562, 2002
12. GONZALEZ C, ALONSO, ARAZ F, PATTERSON AM: Dose-and time-dependent effect of 17β-oestradiol on insulin sensitivity in insulin-dependent tissues of rat: implications of IRS-1. J Endocrinol 176, 367-379, 2003
13. GORODESKI GI: Update on cardiovascular disease in postmenopausal women. Best Pract Res Clin Obstet Gynaecol 16, 329-355, 2002
14. GRIFFITH OW: Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine. Anal Biochem 106, 207-212, 1980
15. GUO H, LEE JD, UEDO T, SHAN J, WANG J: Plasma homocysteine levels in patients with early coronary artery stenosis and high risk factors. JPn Heart J 44, 821-865, 2003
16. HA BJ, LEE SH, KIM HJ, LEE JY: The role of salicornia herbacea in ovariectomy-induced oxidative stress. Biol Pharm Bull 29, 1305-1309, 2006
17. JAARIN K, NORHAYAT M, NORZANA G, NOR AINI U, KIMA-NIRWANA S: Effects of heated vegetable oils on serum lipids and aorta of ovariectomized rats. Pakistan J Nutr 5, 19-29, 2006
18. KANAUCHI M, YAMANO S, KANAUCHI K, SAITO Y: Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high - normal blood pressure. J Clin Endocrinol Metab 88, 3444-3446, 2003
19. KATHERMAN R: Enzymatic colorimetric method for cholesterol determination. J Clin Chem 22, 245-249, 1984
20. KISHIDA T, KIYOSHI E: Ovarian hormone deficiency-induced hypercholesterolemia is reversed by taurine. Nutrition Research 20, 1173-1182, 2000
21. LENTEN BJV, MELCHIOR GW, ROHEIN PS: Lipoprotein metabolism in the ovariectomized rat. J Lipid Res 24, 1473-1484, 1983
22. LI C, SAMSOIE G, et al.: Low-dose hormone therapy and carbohydrate metabolism. Fertil Steril 79,550-555, 2003
23. LIU M-L, XU X, RANG W-Q, LI Y-J, SONG H-P: Influence of avariectomy and 17?-estradiol treatment on insulin sensitive, lipid metabolism and post-ischemic cardiac function. Int J Cardial 97, 483-493, 2004
24. LUCAS EA, CHEN TY, CHAI SC, DEVAREDDY L, JUMA S, WEI CI, TRIPATHI YB, DAGGY BP, HWANG DF, ARJMANDI BH: Effect of vitamin E on lipid parameters in ovariectomized rats. J Med Food 9, 77-83, 2006
25. MARTINS PJF, GALDIERI LC, SOUZA FG, ANDERSEN ML, BENEDITOSILVA AA, TUFIK S, D'ALMEDIA V: Physiological variation in plasma total homocysteine concentration in rats. Life Sciences 76, 2621-2629, 2005
26. MENDELSOHN ME: Protective effects of estrogen on the cardiovascular system. Am J Cardiol 89 (12 suppl), 12E-17E, 2002
27. MIKKOLA TS, CLARKSON TB: Estrogen replacement therapy, atherosclerosis and vascular function. Cardiovasc Res 53, 605-619, 2002
28. OS I, OS A, ABDELNOOR M, LARSEN A, BIRKELAND K, WESTHEIM A: Insulin sensitivity in women with coronary heart disease during hormone replacement therapy. J Womens Health (Larchmt) 14,137-145, 2005
29. PAOLISSO G, DIMARO G, GALZERANO D, CAC-CIAPUOTI F, VARRICCHIO G, VARRICCHIO M, D'ONOFRIO F: Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 59, 1291-1296, 1994
30. PARTICIA C, FALLEST S, DAVID D, JAMES H, PARTICK E: Homocysteine: A new risk factor for atherosclerosis. American Family Physician 56, 1-7, 1997
31. PERSKY DM, GREEN PS, STUBLEY L, HOWLL CO, ZAULYANOV L, BRAZEAU GA, SIMPKINS JW: Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Publication by Society for Experimental and Medicine 23, 59-66, 2000
32. SCHAFER FQ, BUETTNER GR: Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Radic Biol Med 30, 1191-1212, 2001
33. SHOJI T et al.: Inverse relationship between circulating oxidized low density lipoprotein and anti-ox LDL antibody levels in healthy subjects. Atherosclerosis 148, 171-177, 2002
34. STEINMETZ J, TARALLO P, FOURNIER B, CACES E, SIEST G: Reference limits of apolipoprotein A-I and apolipoprotein B using an IFCC standardized immunonephelometric method. Eur J Clin Chem Clin Biochem 33, 337, 1995
35. TRINDER P: Dteremination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6, 24-27, 1969
36. WILLIAMS CM: Cardiovascular risk factor in women. Proc Nutr Soc 56, 383-391, 1997
37. WILLIAMS CM: Lipid metabolism in women. Proc Nutr Soc 63, 153, 2004